Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Interview: Pier Mannuccio Mannucci
4
Mins
March 2024
I think the beginning was when I graduated in the 1960s; my thesis was on red cell enzymes within haematology, but it had nothing to do…
Read more
4
Mins
27th March 2024
Interview: Pier Mannuccio Mannucci
I think the beginning was when I graduated in the 1960s; my thesis was on red cell enzymes within haematology, but it had nothing to do…
8
Mins
4th March 2024
IgD Multiple Myeloma
Multiple myeloma (MM) is a disease characterised by the clonal expansion of malignant plasma cells in the marrow, leading to anaemia…
9
Mins
29th February 2024
Sickle Cell Thalassaemia and Overlapping Syndrome
Sickle cell disease (SCD) is a genetic condition caused by mutations in the haemoglobin (Hb) gene, resulting in various complications. One…
9
Mins
25th January 2024
The AZALEA-TIMI 71 Study and the Future of Factor XI Inhibition: Reflections from the American Heart Association Scientific Congress 2023
Since its earliest days, the effective use of anticoagulation for prevention of stroke and other thromboembolic events has been limited by…
3
Mins
15th January 2024
Interview with the EAHAD Congress President: Wolfgang Miesbach
Wolfgang Miesbach, Professor of Medicine, Frankfurt University Hospital, Germany; Congress President, European Association for Haemophilia…
4
Mins
22nd December 2023
Bone Disorder Transformed Into Amyloidoma
Amyloidosis results from a misconfiguration of normal protein into β-plated linear sheets, leading to the formation and deposition of…
12
Mins
18th December 2023
Expert Recommendations on Balancing the Risk and Mitigation Strategies of Veno-occlusive Disease When Treating Adult Relapsed or Refractory B-cell Acute Lymphoblastic Leukaemia with Inotuzumab Ozogamicin▼
The publication of this article was initiated and funded by Pfizer. This article is intended for UK Healthcare Professionals only. The Prescribing Information for Inotuzumab Ozogamicin and Adverse Event Reporting can be found within the article.
9
Mins
15th December 2023
Pyruvate Kinase Deficiency in Children
Pyruvate kinase (PK) deficiency is a hereditary haemolytic anaemia caused by mutations in the PKLR gene encoding PK, which is critical…
11
Mins
14th September 2023
Improving the Effectiveness of Anticoagulant Therapy: The Promise of Factor XI Inhibition
This continuing medical education-accredited symposium, held at the 2023 International Society for Thrombosis and Haemostasis (ISTH)…
7
Mins
1st August 2023
Expert Insights: Phase III Clinical Trials in Non-Transfusion-Dependent (ENERGIZE) and Transfusion-Dependent (ENERGIZE-T) α- and β-Thalassaemia
The thalassaemias are a heterogeneous group of inherited chronic blood disorders associated with impaired haemoglobin (Hb) synthesis…
9
Mins
1st August 2023
What to Do When Chimeric Antigen Receptor T Cells Are Not the Most Appropriate Option in Second-Line Diffuse Large B Cell Lymphoma: Current Treatment Options for Transplant-Ineligible Patients
DLBCL accounts for approximately 30% of non-Hodgkin’s lymphomas diagnosed each year. Initially, DLBCL is generally treated…
8
Mins
20th July 2023
Untangling Systemic Mastocytosis: An Update on Challenges in the Diagnosis and Treatment of Myeloid Neoplasms with Systemic Mastocytosis
The overarching message from the symposium was that diagnosis of SM-AHN is challenging, and SM is often missed in patients with a myeloid…
8
Mins
20th July 2023
Steroid Toxicity in Immune Thrombocytopaenia
This article summarises the occurrence of very unusual and rare steroid-related toxicity. It is a cautionary tale of modern medicine where the treatment-related adverse events are more atrocious than the primary disease.
5
Mins
30th May 2023
Interview: Janis Abkowitz
Janis Abkowitz | Head, Division of Hematology, University of Washington, Seattle, USA; Adjunct Professor of Genome Sciences, University of…
6
Mins
19th May 2023
Interview: Cynthia Dunbar
Cynthia Dunbar – Secretary, American Society of Hematology (ASH); Chief, Translational Stem Cell Biology Branch, and Head, Molecular…
11
Mins
15th February 2023
Realising the Promise of Gene Therapy for Haemophilia: Current Status and Future Innovations
Gene therapy for haemophilia A and B was discussed during several sessions at the 64th American Society of Hematology (ASH) Annual Meeting, held 10th–13th December 2022.
Loading posts...
« Previous
1
2
3
4
…
21
Next »